TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ASPI

ASP Isotopes Inc.

Basic Materials · Chemicals

2.90$ +0.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

ASP Isotopes Inc. (ASPI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 572 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ASPI
Line item Q2 20 Q3 20 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 308 – 7.1 8.9 10 9.5 12 15 13 12 28 45 55 84 94 91 136 226 498 588 572
– 48 – 3.2 4.0 3.6 1.6 3.3 5.8 4.0 2.7 11 26 32 56 66 59 102 174 400 309 272
– 44 – 3.0 3.8 2.8 0.4 2.4 5.1 3.6 2.3 7.9 24 28 52 62 56 68 114 286 207 220
– 44 – 3.0 3.8 2.8 0.4 2.4 5.1 3.6 2.3 – 24 28 52 62 56 68 114 – 291 255
– 0.4 – – – – 0.4 – – – – 0.2 0.4 0.5 0.6 0.7 0.7 31 50 18 4.6 4.6
– – – – – – -0.4 – – – – – – 0.0 0.1 0.1 0.3 1.0 1.4 1.1 1.4 1.5
– – – – 4.8 6.5 6.9 – – 7.7 – – – – – – – – – – – –
– – – – – – – – – – – 3.3 3.2 3.3 3.5 3.2 3.3 3.4 6.8 8.6 6.4 6.5
– – – – – – – – – – – – – – – – – – 1.2 1.5 0.7 0.6
5.5 4.1 – 1.1 1.9 2.6 3.2 2.7 2.7 2.6 3.2 8.7 32 40 42 43 45 108 129 235 289 297
2.8 4.1 – 0.3 1.0 1.8 2.5 1.9 2.0 1.9 2.6 5.7 7.3 8.0 7.4 7.1 8.2 6.9 28 33 70 70
– – – 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 – 0.8 1.4 1.3 1.6 1.5 1.0 13 – 54 56
1.7 2.0 – 0.1 0.4 0.9 1.2 1.4 1.3 0.7 0.4 1.1 2.2 2.4 1.8 1.0 2.0 2.6 3.4 5.8 6.9 5.7
– – – – – – – – – – – – 22 29 32 35 36 100 100 201 205 209
– 300 – 6.0 7.0 7.4 6.3 9.8 12 10 8.6 16 11 11 39 48 43 25 74 204 289 265
– – – -2.6 -3.5 -4.3 -6.2 -7.6 -11 -15 -20 -24 -31 -40 -47 -56 -65 -140 -153 -231 -239 -273
– 31 34 31 31 31 32 36 29 30 31 49 45 49 62 56 69 73 89 112 121 123

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?